124 related articles for article (PubMed ID: 36469427)
1. Discrete and continuum models for the coevolutionary dynamics between CD8+ cytotoxic T lymphocytes and tumour cells.
Almeida L; Audebert C; Leschiera E; Lorenzi T
Math Med Biol; 2023 Jun; 40(2):141-174. PubMed ID: 36469427
[TBL] [Abstract][Full Text] [Related]
2. A Hybrid Discrete-Continuum Modelling Approach to Explore the Impact of T-Cell Infiltration on Anti-tumour Immune Response.
Almeida L; Audebert C; Leschiera E; Lorenzi T
Bull Math Biol; 2022 Oct; 84(12):141. PubMed ID: 36315362
[TBL] [Abstract][Full Text] [Related]
3. Suppression of murine tumour growth through CD8
Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
[TBL] [Abstract][Full Text] [Related]
4. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
5. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
7. A dynamical model of tumour immunotherapy.
Frascoli F; Kim PS; Hughes BD; Landman KA
Math Biosci; 2014 Jul; 253():50-62. PubMed ID: 24759513
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo specific induction of CD8 positive anti-leukemia cytotoxic lymphocytes from umbilical cord blood.
Tan H; Liu X; Ye X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):129-33. PubMed ID: 17490538
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T cells swarm by homotypic chemokine signalling.
Galeano Niño JL; Pageon SV; Tay SS; Colakoglu F; Kempe D; Hywood J; Mazalo JK; Cremasco J; Govendir MA; Dagley LF; Hsu K; Rizzetto S; Zieba J; Rice G; Prior V; O'Neill GM; Williams RJ; Nisbet DR; Kramer B; Webb AI; Luciani F; Read MN; Biro M
Elife; 2020 Oct; 9():. PubMed ID: 33046212
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
[TBL] [Abstract][Full Text] [Related]
11. Evasion of tumours from the control of the immune system: consequences of brief encounters.
Al-Tameemi M; Chaplain M; d'Onofrio A
Biol Direct; 2012 Sep; 7():31. PubMed ID: 23009638
[TBL] [Abstract][Full Text] [Related]
12. Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.
Ohmura Y; Yoshikawa K; Saga S; Ueda R; Kazaoka Y; Yamada S
Oncol Rep; 2008 May; 19(5):1265-70. PubMed ID: 18425386
[TBL] [Abstract][Full Text] [Related]
13. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK
J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY
Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856
[TBL] [Abstract][Full Text] [Related]
16. Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.
Matzavinos A; Chaplain MA; Kuznetsov VA
Math Med Biol; 2004 Mar; 21(1):1-34. PubMed ID: 15065736
[TBL] [Abstract][Full Text] [Related]
17. CD4
Wang B; Hu S; Fu X; Li L
Adv Biol (Weinh); 2023 Apr; 7(4):e2200169. PubMed ID: 36193961
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
Front Immunol; 2019; 10():2076. PubMed ID: 31552033
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of proliferating CD8
Blessin NC; Li W; Mandelkow T; Jansen HL; Yang C; Raedler JB; Simon R; Büscheck F; Dum D; Luebke AM; Hinsch A; Möller K; Menz A; Bernreuther C; Lebok P; Clauditz T; Sauter G; Marx A; Uhlig R; Wilczak W; Minner S; Krech T; Fraune C; Höflmayer D; Burandt E; Steurer S
Cell Oncol (Dordr); 2021 Aug; 44(4):793-803. PubMed ID: 33864611
[TBL] [Abstract][Full Text] [Related]
20. Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
Kawashima H; Obayashi A; Kawamura M; Masaki S; Tamada S; Iguchi T; Uchida J; Kuratsukuri K; Tanaka T; Nakatani T
BJU Int; 2014 Feb; 113(2):320-32. PubMed ID: 24895689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
